A Phase 2a study evaluating mebendazole (polymorphism C) in patients with advanced gastrointestinal cancer treated patients with up to 4g/day mebendazole with a target serum concentration of 300ng/mL
At Club Five Health, we harness that potential to help you look, feel, and perform at your besttoday, and for the long run.
Masnec, S., Kokot, A., Zlatar, M., Kalauz, M., Radi, B., Klicek, R., Drmic, D., Lazi, R., Seiwerth, S., & Sikiric, P
Understanding these differences prevents wasted money and ensures effective treatment
Stable Gastric Pentadecapeptide BPC 157 in the Treatment of Various Tissue Healing